Patients exhibiting high PSAT1 and SLC1A5 expression were more likely to develop lymph node metastasis, while high PHGDH, PSPH and SLC1A5 expression were associated with distant metastasis (Figures 2B and S7D–F). Here, PSPH is linked to metastatic malignant neoplasm in the lymph nodes.